Abstract
High dose vitamin A (HDVA) concentrate began to be distributed in India in 1970 as a short-term, stop-gap approach to reduce clinical signs of vitamin A deficiency. As this problem declined globally, the purpose of distributing them changed to the reduction of young child mortality. However, their impact on this has also declined, if not disappeared, as suggested in India by the enormous DEVTA study. This may be because of improved protection against and treatment of the main morbidity involved, measles and diarrhea. At the same time, semi-annual provision of mega-doses of vitamin A is not without risks, in particular linked to children’s vaccination status. While a single dose is inexpensive, large-scale implementation of HDVA programs is expensive, particularly the opportunity cost involved in reducing the time health workers involved have to deal with their other commitments. Balancing potential benefits, risks and costs leads us to recommend an immediate cessation of the distribution of HDVA in India.
Similar content being viewed by others
References
Laxmaiah A, Nair MK, Arlappa N, et al. Prevalence of ocular signs and subclinical vitamin A deficiency and its determinants among rural pre-school children in India. Public Health Nutr. 2012;15:568–77.
Mason J, Greiner T, Shrimpton R, Sanders D, Yukich J. Vitamin A policies need rethinking. Int J Epidemiol. 2015;44:283–92.
Pedro MR, Madriaga JR, Barba CV, et al. The national vitamin A supplementation program and subclinical vitamin A deficiency among preschool children in the Philippines. Food Nutr Bull. 2004;25:319–29.
Mason JB, Ramirez MA, Fernandez CM, et al. Effects on vitamin A deficiency in children of periodic high-dose supplements and of fortified oil promotion in a deficient area of the Philippines. Int J Vitam Nutr Res. 2011;81:295–305.
WHO. Essential Nutrition Actions: Improving maternal, newborn, infant and young child health and nutrition. Geneva: WHO . Available at: http://apps.who.int/iris/bitstream/10665/84409/1/9789241505550_eng.pdf 2013. Accesssed 13 Dec 2018.
Beaton GH, Martorell R, Aronson KJ, et al. Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. In: Mason JB, editor. ACC/SCN State-of-the-Art Series. Toronto: University of Toronto; 1993. p. 120.
Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA. 1993;269:898–903.
WHO Guideline. Vitamin A supplementation in infants and children 6–59 months of age. Geneva: WHO; 2011.
UNICEF. State of the World's Children. New York: UNICEF; 2016.
Villamor E, Fawzi WW. Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis. 2000;182:S122–33.
Benn CS, Aaby P, Arts RJ, Jensen KJ, Netea MG, Fisker AB. An enigma: why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality. Int J Epidemiol. 2015;44:906–18.
Ramakrishnan U, Latham MC, Abel R, Frongillo EA Jr. Vitamin A supplementation and morbidity among preschool children in South India. Am J Clin Nutr. 1995;61:1295–303.
Herrera MG, Nestel P, el Amin A, Fawzi WW, Mohamed KA, Weld L. Vitamin A supplementation and child survival. Lancet. 1992;340:267–71.
Vijayaraghavan K, Radhaiah G, Prakasam BS, Sarma KV, Reddy V. Effect of massive dose vitamin A on morbidity and mortality in Indian children. Lancet. 1990;336:1342–5.
Stansfield SK, Pierre-Louis M, Lerebours G, Augustin A. Vitamin A supplementation and increased prevalence of childhood diarrhoea and acute respiratory infections. Lancet. 1993;342:578–82.
Barclay AJ, Foster A, Sommer A. Vitamin A supplements and mortality related to measles: a randomised clinical trial. Br Med J (Clin Res Ed). 1987;294:294–6.
Benn CS, Aaby P, Nielsen J, Binka FN, Ross DA. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial. Am J Clin Nutr. 2009;90:629–39.
Awasthi S, Peto R, Read S, Clark S, Pande V, Bundy D. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in North India: DEVTA, a cluster-randomised trial. Lancet. 2013;381:1469–77.
Fisker AB, Bale C, Rodrigues A, et al. High-dose vitamin A with vaccination after 6 months of age: a randomized trial. Pediatrics. 2014;134:e739–48.
Stevens GA, Bennett JE, Hennocq Q, et al. Trends and mortality effects of vitamin A deficiency in children in 138 low-income and middle-income countries between 1991 and 2013: a pooled analysis of population-based surveys. Lancet Glob Health. 2015;3:e528–36.
Bahreynian M, Qorbani M, Naderimagham S, et al. Burden of disease attributable to vitamin A deficiency in Iranian population aged less than five years: findings from the global burden of disease study 2010. J Diabetes Metab Disord. 2017;16:32.
Mitra AK, Alvarez JO, Wahed MA, Fuchs GJ, Stephensen CB. Predictors of serum retinol in children with shigellosis. Am J Clin Nutr. 1998;68:1088–94.
Alvarez JO, Salazar-Lindo E, Kohatsu J, Miranda P, Stephensen CB. Urinary excretion of retinol in children with acute diarrhea. Am J Clin Nutr. 1995;61:1273–6.
Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011;343:d5094.
WHO. State of the World's Vaccines and Immunization. Geneva: World Health Organization; 2009.
Bhatnagar P, Gupta S, Kumar R, Haldar P, Sethi R, Bahl S. Estimation of child vaccination coverage at state and national levels in India. Bull World Health Organ. 2016;94:728–34.
Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2197–223.
Kapil U, Sareen N. Adverse side effects of mega dose of vitamin A administration- a need for introspection. World Nutr. 2017;8:71–8.
Doherty T, Chopra M, Tomlinson M, Oliphant N, Nsibande D, Mason J. Moving from vertical to integrated child health programmes: experiences from a multi-country assessment of the child health days approach in Africa. Trop Med Int Health. 2010;15:296–305.
Hanvoravongchai PM-JS, Oliveira Cruz V, Balabanova D, et al. Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis. 2011;204:S82–9.
Verguet SJW, Bertram MY, Tollman SM, et al. Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa. J Epidemiol Community Health. 2013;67:947–52.
Blomhoff R, Green MH, Norum KR. Vitamin A: physiological and biochemical processing. Ann Rev Nutr. 1992;12:37–57.
Wirth JP, Petry N, Tanumihardjo SA, et al. Vitamin A supplementation programs and country-level evidence of vitamin A deficiency. Nutrients. 2017;9:pii:E190.
Arts RJ, Blok BA, van Crevel R, et al. Vitamin A induces inhibitory histone methylation modifications and down-regulates trained immunity in human monocytes. J Leukoc Biol. 2015;98:129–36.
Author information
Authors and Affiliations
Contributions
All the four authors contributed to the writing of this article and each has read and agreed to the wording in the final, submitted version.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Greiner, T., Mason, J., Benn, C.S. et al. Does India Need a Universal High-Dose Vitamin A Supplementation Program?. Indian J Pediatr 86, 538–541 (2019). https://doi.org/10.1007/s12098-018-02851-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-018-02851-x